AmInvest Research Reports

MPI - Strong 1H but expect subdued demand onwards

AmInvest
Publish date: Thu, 27 Feb 2020, 10:53 AM
AmInvest
0 9,388
An official blog in I3investor to publish research reports provided by AmInvest research team.

All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx

Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com

Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)

Investment Highlights

  • We downgrade our recommendation on Malaysian Pacific Industries (MPI) to HOLD from BUY with a lower fair value of RM11.64/share (previously RM12.45/share), pegged to an CY20F PE of 14x which is in line with regional peers’ 1-year forward PE.
  • MPI’s 2QFY20 results came in at RM53mil, bringing 1HFY20 core profit to RM93mil, in line with expectations. This is after adjusting for RM11mil one-off losses mainly from forex losses of RM7mil and provision & write-off of inventories of RM3mil. The results account for 56% of our full-year forecasts and 61% of consensus’ estimates.
  • We consider the results to be in line as 1H results for MPI historically accounts for an average of 58–61% of full-year earnings i.e. slightly higher than 2H results. However, we have lowered FY20F–FY22F earnings forecasts by 4–10% due to the impact of the coronavirus disease 2019 (Covid-19) outbreak, as the group expects a softer demand for 2HFY20 which impacts MPI’s end-user markets.
  • YoY: 1HFY20 core profit declined 3% as revenue fell 4% despite lower effective tax, minority interests and finance costs, and cost savings. Revenue in Asia was flattish but sales in the USA and Europe declined by 16% and 3% respectively as customers held back orders due to the US-China trade war.
  • QoQ: 2QFY20 core profit climbed 32% due to better efficiencies as revenue went up 12%. Revenue rose across its key markets where revenue in Asia rose 14%, the USA was up 6% while Europe increased by 13%.
  • EBITDA margins improved by 1.4ppt YoY and 2.3ppt QoQ, likely due to MPI’s portfolio rationalization initiative, and digitalization and automation efforts translating to cost savings.
  • Despite strong 1HFY20 results, Covid-19 has caused uncertainties for MPI’s 2HFY20 earnings, particularly for its Carsem operations in Suzhou, China. MPI’s revenue exposure to China is approximately 30%. The group said that its utilization rate during the Lunar New Year Holiday was 75– 80% up till 8 February 2020. We expect to gain further clarity on the status of its Suzhou operations since then, at a briefing later today.
  • We continue to like MPI due to its: (i) new product portfolio that focuses on higher-margin projects; (ii) leading market position in the ultra-thin MLP and increased R&D in MEMS sensor riding on the IoT wave; and (iii) strong net cash position of RM801mil which allows it to look for meaningful M&A opportunities. However, we note that Covid-19 plagues its near-term outlook and now recommend a HOLD

Source: AmInvest Research - 27 Feb 2020

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment